Dr. Oleksandr Halytskyy, MD

Dr. Halytskyy practices at Ozarks Healthcare in West Plains, Missouri, part of Ozarks Healthcare.

Dr. Halytskyy's NPI, 1386084630, was assigned on July 1, 2013. Dr. Halytskyy holds Missouri license 2017017854.

Dr. Halytskyy's primary practice is Ozarks Healthcare, at 1100 Kentucky Ave, West Plains, MO 65775 in Howell County. The practice phone is (417) 256-9111.

Dr. Halytskyy's primary practice is Ozarks Healthcare in West Plains, Missouri, part of Ozarks Healthcare. Dr. Halytskyy is also affiliated with Mercy Hospital Springfield. The medical group on file is Ozarks Healthcare General Surgery. Dmand AI also links Dr. Halytskyy to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Halytskyy practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Halytskyy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Halytskyy's licenses on file in 3 states: Missouri, Illinois and Rhode Island.

CMS data shows 582 Medicare services from Dr. Halytskyy across 6 procedure codes in 2024, for 208 Medicare patients. Medicare paid $45,736 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Dr. Halytskyy in 2024. The largest group is 75 to 84, with 70 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Halytskyy's median patient age at 75, with 53% women.

In 2024, Dr. Halytskyy wrote 384 Medicare Part D claims for 151 patients. 87% of them were for generic drugs. CMS names the drug for 192 of them, across 10 drugs with 11 or more claims each, at $13,834 in total drug cost. In 2023, CMS named 211 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Halytskyy for performance year 2024, reported as part of a group. Dr. Halytskyy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Halytskyy, published from 2014 to 2019. 2015 was the busiest year, with 3. The most frequent topics are Alcohol Drinking, Cancer Survivors and Exercise. Dr. Halytskyy's most frequent co-authors are Alaa Ali, MD, Aibek Mirrakhimov, MD and Prakruthi Venkata Voore, MD.

CMS Open Payments shows 4 general payments to Dr. Halytskyy from 4 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $18.